Beijing InnoCare Pharma Tech Co., Ltd.
2 clinical trials · 2 recruiting · INDUSTRY
Trials by Beijing InnoCare Pharma Tech Co., Ltd.
RECRUITINGPhase 3NCT06082102
Efficacy and Safety of Orelabrutinib Combined With Rituximab Versus Lenalidomide Combined With Rituximab in Patients...
Efficacy and Safety of Orelabrutinib Combined with Rituximab versus Lenalidomide Combined with Rituximab in Patients with Relapsed/Refractory Marginal Zone Lymphoma
Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.Enrolling: 32419 locations
Relapsed/Refractory Marginal Zone Lymphoma
RECRUITINGPhase 2NCT05688696
Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Systemic Lupus Erythematosus
This is a phase IIb, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of orelabrutinib in adult subjects with SLE who are...
Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.Enrolling: 18620 locations
Systemic Lupus Erythematosus, SLE